Gilles Clapisson

1.3k total citations
22 papers, 559 citations indexed

About

Gilles Clapisson is a scholar working on Oncology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gilles Clapisson has authored 22 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 5 papers in Hematology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gilles Clapisson's work include Neutropenia and Cancer Infections (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Blood disorders and treatments (3 papers). Gilles Clapisson is often cited by papers focused on Neutropenia and Cancer Infections (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Blood disorders and treatments (3 papers). Gilles Clapisson collaborates with scholars based in France, United States and Belgium. Gilles Clapisson's co-authors include Jean‐Yves Blay, Irène Philip, Christine Ménétrier‐Caux, Christophe Borg, Pierre Biron, Isabelle Ray‐Coquard, Toshiyuki Fujii, Philippe Télouk, Alain Puisieux and Victor P. Bondanese and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Gilles Clapisson

21 papers receiving 552 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gilles Clapisson France 10 330 162 82 69 65 22 559
Eleanor V. Willett United Kingdom 14 331 1.0× 103 0.6× 281 3.4× 24 0.3× 59 0.9× 22 1.0k
D Banerjee Canada 14 319 1.0× 169 1.0× 192 2.3× 157 2.3× 127 2.0× 38 961
Manuela Giachelia Italy 14 252 0.8× 92 0.6× 124 1.5× 16 0.2× 50 0.8× 21 649
Toshiyuki Sado Japan 18 79 0.2× 325 2.0× 170 2.1× 29 0.4× 68 1.0× 51 1.2k
Mary Waugh United States 14 100 0.3× 294 1.8× 191 2.3× 53 0.8× 18 0.3× 17 644
Kazunori Kanehira United States 16 228 0.7× 64 0.4× 141 1.7× 17 0.2× 113 1.7× 27 580
Roxane Lemoine France 14 70 0.2× 102 0.6× 126 1.5× 16 0.2× 110 1.7× 36 543
A Ramoni Austria 13 105 0.3× 128 0.8× 163 2.0× 13 0.2× 36 0.6× 21 717
Randy A. Brown United States 17 384 1.2× 187 1.2× 322 3.9× 31 0.4× 61 0.9× 39 1.1k
Fotini Tzortzatou Greece 10 138 0.4× 37 0.2× 86 1.0× 18 0.3× 37 0.6× 24 577

Countries citing papers authored by Gilles Clapisson

Since Specialization
Citations

This map shows the geographic impact of Gilles Clapisson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilles Clapisson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilles Clapisson more than expected).

Fields of papers citing papers by Gilles Clapisson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilles Clapisson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilles Clapisson. The network helps show where Gilles Clapisson may publish in the future.

Co-authorship network of co-authors of Gilles Clapisson

This figure shows the co-authorship network connecting the top 25 collaborators of Gilles Clapisson. A scholar is included among the top collaborators of Gilles Clapisson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gilles Clapisson. Gilles Clapisson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ortiz‐Cuaran, Sandra, Aurélie Swalduz, Séverine Martinez, et al.. (2018). Abstract 937: Longitudinal circulating-tumor DNA profiling of EGFR-mutated non-small cell lung cancer patients treated with EGFR-tyrosine kinase inhibitors. Cancer Research. 78(13_Supplement). 937–937.
2.
3.
Pleșa, Adriana, Mohamed Elhamri, Gilles Clapisson, et al.. (2014). Higher percentage of CD34 + CD38− cells detected by multiparameter flow cytometry from leukapheresis products predicts unsustained complete remission in acute myeloid leukemia. Leukemia & lymphoma. 56(3). 622–629. 9 indexed citations
4.
Télouk, Philippe, Alain Puisieux, Toshiyuki Fujii, et al.. (2014). Copper isotope effect in serum of cancer patients. A pilot study. Metallomics. 7(2). 299–308. 100 indexed citations
5.
Campone, M., Christelle Lévy, Mónica Arnedos, et al.. (2013). Abstract S6-07: Genomic characterisation of metastatic samples from breast cancer patients using next generation sequencing. Cancer Research. 73(24_Supplement). S6–7. 2 indexed citations
6.
Trédan, Olivier, Manuarii Manuel, Gilles Clapisson, et al.. (2012). Patients with metastatic breast cancer leading to CD4+ T cell lymphopaenia have poor outcome. European Journal of Cancer. 49(7). 1673–1682. 44 indexed citations
7.
Manuel, Manuarii, Olivier Trédan, Thomas Bachelot, et al.. (2012). Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients. OncoImmunology. 1(4). 432–440. 101 indexed citations
8.
Péron, Julien, Claire Cropet, Olivier Trédan, et al.. (2012). CD4 lymphopenia to identify end-of-life metastatic cancer patients. European Journal of Cancer. 49(5). 1080–1089. 30 indexed citations
9.
Péron, Jean‐Marie, I. L. Ray-Coquard, Sana Intidhar Labidi‐Galy, et al.. (2011). Association of CD4 lymphopenia with survival in patients with advanced cancer.. Journal of Clinical Oncology. 29(15_suppl). e21145–e21145. 1 indexed citations
10.
Carausu, Liana, et al.. (2007). Use of totally implantable catheters for peripheral blood stem cell apheresis. Bone Marrow Transplantation. 40(5). 417–422. 7 indexed citations
11.
Prébet, Thomas, Isabelle Tigaud, Sandrine Hayette, et al.. (2005). Mobilization of autologous hematopoietic progenitors and subsequent transplantation is a safe and feasible procedure in chronic phase chronic myelogenous leukemia patients with cytogenetic resistance to imatinib.. PubMed. 90 Suppl. ECR36–ECR36. 1 indexed citations
12.
Borg, Christophe, Isabelle Ray‐Coquard, Irène Philip, et al.. (2004). CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer. Cancer. 101(11). 2675–2680. 73 indexed citations
13.
Delannoy, Bertrand, Franck E. Nicolini, Quoc‐Hung Le, et al.. (2004). Impact on Transplant Outcome of Karyotyping Analysis in Apheresis Products for Autologous PBSC Transplantation in De Novo Acute Leukemias (AL).. Blood. 104(11). 1871–1871. 1 indexed citations
14.
Clapisson, Gilles, et al.. (2004). Cryopreservation with hydroxyethylstarch (HES) + dimethylsulfoxide (DMSO) gives better results than DMSO alone.. PubMed. 91(4). E97–102. 25 indexed citations
15.
Ray‐Coquard, Isabelle, Christophe Borg, Catherine Sebban, et al.. (2003). Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy. British Journal of Cancer. 88(2). 181–186. 85 indexed citations
16.
Archimbaud, E, Mauricette Michallet, I Philip, et al.. (1997). Granulocyte colony‐stimulating factor given in addition to interferon‐α to mobilize peripheral blood stem cells for autologous transplantation in chronic myeloid leukaemia. British Journal of Haematology. 99(3). 678–684. 14 indexed citations
17.
Favrot, M, Thierry Philip, Yacine Merrouche, et al.. (1992). Treatment of Patients with Advanced Cancer Using Tumor Infiltrating Lymphocytes Transduced with the Gene of Resistance to Neomycin. Centre Léon Bérard, Lyon, France. Human Gene Therapy. 3(5). 533–542. 5 indexed citations
18.
Favrot, M, et al.. (1991). Functional and phenotypic modifications induced by IL-4, as single agent or in combination with IL-2, on PBMC preactivated in vivo by alpha-interferon + interleukin-2 therapy.. PubMed. 1(3). 141–7. 1 indexed citations
19.
Favrot, M, Valérie Combaret, Jean‐Yves Blay, et al.. (1991). TNF alpha enhancement of NK and LAK cell functions induced by high-dose IL-2 in human peripheral blood mononuclear cells from patients pretreated with alpha IFN + IL-2.. PubMed. 1(4). 221–7. 4 indexed citations
20.
Bruneau, Bertrand, et al.. (1990). Hémodilution et autotransfusion peropératoire dans les prélèvements pour greffe de moelle osseuse. Annales Françaises d Anesthésie et de Réanimation. 9(6). 480–484. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eleanor V. Willett Breakdown of academic impact, for papers by D Banerjee Breakdown of academic impact, for papers by Manuela Giachelia Breakdown of academic impact, for papers by Toshiyuki Sado Breakdown of academic impact, for papers by Mary Waugh Breakdown of academic impact, for papers by Kazunori Kanehira Breakdown of academic impact, for papers by Roxane Lemoine Breakdown of academic impact, for papers by A Ramoni Breakdown of academic impact, for papers by Randy A. Brown Breakdown of academic impact, for papers by Fotini Tzortzatou
Rankless by CCL
2026